Home / Tag Archives: gene-based drug

Tag Archives: gene-based drug

Engility Lands $112M FDA Computational Science, Bioinformatics Services IDIQ; Lynn Dugle Comments

The Food and Drug Administration has awarded Engility (NYSE: EGL) a potential five-year, $112 million indefinite-delivery/indefinite-quantity contract to provide computational science and bioinformatics services for the FDA’s gene-based drug discovery and development programs. Engility said Thursday it will help the FDA operate, secure and maintain scientific computing environments and systems designed …

Read More »